Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

Learn more here
All
  • All
  • News
  • Articles
  • Events
October 19, 2023

ISMPP Academy report: Oxford PharmaGenesis teaches how to elevate publications through enhanced impact and demystifies RWE and HEOR

More than 150 medical publications professionals gathered in Philadelphia on 28–29 September 2023 for the inaugural ISMPP Academy. Oxford PharmaGenesis was a key event sponsor and we were delighted to give two valuable presentations to help attendees to explore new frontiers in publications. In line with the ISMPP Academy theme ‘PREP! Practical Resources to Elevate…

Continue reading
October 17, 2023

Celebrating five colleagues who have dedicated more than 20 years to Oxford PharmaGenesis

We are thrilled to celebrate five colleagues who have dedicated more than 20 years to Oxford PharmaGenesis! They have helped to deliver everything from traditional medical communications to innovative patient engagement materials, not only serving our clients but also advancing our company mission along the way.

Continue reading
Clinical study publication
October 6, 2023

Factors influencing the time it takes for the results from pharmaceutical industry-affiliated clinical studies to be published

The publication of clinical study results is key to communicating how well medicines can treat diseases. It is vital that these results are made available as quickly as possible, so it’s important to know what influences the ‘time to publication’ (the time from the end of the study to publication of the results in a…

Continue reading
September 11, 2023

ISMPP Academy | Elevate and enrich publications plans with Oxford PharmaGenesis

Effective innovation happens when we ask big questions. It’s part of what makes Oxford PharmaGenesis an award-winning, independent, global HealthScience communications consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration, Open Pharma, social media, and more.

Continue reading
July 18, 2023

Use of ORCID digital identity tags in research funded by pharma companies

ORCID iDs are digital identity tags for authors of research papers. Authors who sign up to ORCID are given a unique number, which is linked to an online profile where they can add information about where they work and their education, awards and published works. Authors can add their ORCID iD to any research papers…

Continue reading
King's Award
July 10, 2023

Oxford PharmaGenesis wins prestigious King's Award

We were honoured on Friday as King Charles III’s representative in Oxfordshire, Lord-Lieutenant Marjorie Glasgow BEM, presented our HealthScience Communications Consultancy with a 2023 King’s Award at our head office just outside Oxford, UK.

Continue reading